EditorWe thank Ciccarese et al. for their interest in our report.They wonder whether the patients that we reported definitely had demodicidosis associated with rosacea, and above all, they provide their own interesting findings in 60 patients with rosacea, findings that we will not comment here.We agree that skin scraping with a D. folliculorum count is certainly the less unreliable way to support a diagnosis of demodicidosis. We did not perform this test, as in our experience, strong itching in papulopustular rosacea in individuals with immune deficiency is always associated with D. folliculorum proliferation. Furthermore, the key message of our publication was to report the factual occurrence of rosacea segregating with GOF STAT1 mutations in a well‐investigated family, the infection with D. folliculorum being only one possible causative explanation.To respond to their questions, we treated the two individuals (children) who complained about itch. A single dose of ivermectin 200 microgram/kg resulted in almost complete amelioration that lasted about 1–2 months, and treatment was repeated on demand.ReferencesLipsker D, Second J, Korganow AN, Jannier S, Puel A. Rosacea and demodicidosis associated with gain‐of‐function mutation in STAT1. J Eur Acad Dermatol Venereol 2017. https://doi.org/10.1111/jdv.14413.Ciccarese J, Parodi A, Rebora A, Drago AE. The usefulness of investigating the possible underlying conditions in rosacea. J Eur Acad Dermatol Venereol 2017. https://doi.org/10.1111/jdv.14547.
Journal of the European Academy of Dermatology & Venereology – Wiley
Published: Jan 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera